Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Research Article

Ultrasound Diagnosis of Renal Cell Carcinoma associated with Xp11.2 Translocation/TFE3 Gene Fusion in Children and Adolescents

Author(s): Ling-ling Deng, Fuqian Wang, Qinhua Luan, Wei Liu, Jianbo Teng and Yongguang Ban*

Volume 20, 2024

Published on: 24 August, 2023

Article ID: e200723218924 Pages: 7

DOI: 10.2174/1573405620666230720103049

Price: $65

conference banner
Abstract

Background: Many studies have reported Xp 11.2 translocation renal cancer in radioimaging,but there is little literature on the evaluation of Xp11.2 translocation renal cell carcinoma by ultrasound.

Objective: To investigate the ultrasonographic features and diagnostic value of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in children and adolescents.

Materials and Methods: The clinical and ultrasonographic data of 10 patients with renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion confirmed by pathology in our hospital were analyzed retrospectively. The age ranged from 3 to 18 years old, including 7 males and 3 females. The tumor location, size, boundary, echo, hemorrhage, cystic change, calcification, blood flow, lymph node status and metastasis were mainly observed, and the results were compared with the pathological results.

Results: There were 10 masses in 10 cases of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion, including 4 in the right kidney and 6 in the left kidney; the maximum diameter line is 5-23cm; 9 cases had clear mass boundary (90%); 9 masses (90%) showed mixed cystic and solid masses with high echo of solid components, and 1 mass (10%) showed huge multilocular cystic mass with multiple septations; necrosis and cystic changes were seen in all 10 masses (100%); calcification in 5 masses (50%); blood flow signals were seen in the solid components of the mass (100%).

Conclusion: Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in children and adolescents are mostly large cystic and solid mixed echo masses, with high echo of solid components, and often accompanied by cystic changes and calcification. Its ultrasonic manifestations have certain characteristics. Color Doppler ultrasound has a certain diagnostic value for this disease.

[1]
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol 2006; 49(5): 798-805.
[http://dx.doi.org/10.1016/j.eururo.2005.11.035] [PMID: 16442207]
[2]
Kmetec A, Jeruc J. Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype. Radiol Oncol 2014; 48(2): 197-202.
[http://dx.doi.org/10.2478/raon-2013-0077] [PMID: 24991210]
[3]
Dai C, Sheng R, Ding Y, Yang M, Hou J, Zhou J. Magnetic resonance imaging findings of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in adults: A pilot study. Abdom Radiol 2019; 44(1): 209-17.
[http://dx.doi.org/10.1007/s00261-018-1703-0] [PMID: 30019296]
[4]
He J, Gan W, Liu S, et al. Dynamic computed tomographic features of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions. J Comput Assist Tomogr 2015; 39(5): 730-6.
[http://dx.doi.org/10.1097/RCT.0000000000000263] [PMID: 25955396]
[5]
Zhu QQ, Wang ZQ, Zhu WR, Chen WX, Wu JT. The multislice CT findings of renal carcinoma associated with XP11.2 translocation/TFE gene fusion and collecting duct carcinoma. Acta Radiol 2013; 54(3): 355-62.
[http://dx.doi.org/10.1258/ar.2012.120255] [PMID: 23446748]
[6]
Tsuda K, Kinouchi T, Tanikawa G, et al. Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging. Int J Urol 2005; 12(9): 795-800.
[http://dx.doi.org/10.1111/j.1442-2042.2005.01126.x] [PMID: 16201974]
[7]
Caliò A, Brunelli M, Segala D, et al. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: Investigating prognostic markers and therapy targets. Pathology 2020; 52(3): 297-309.
[http://dx.doi.org/10.1016/j.pathol.2019.11.006] [PMID: 32107074]
[8]
He J, Huan Y, Qiao Q, Zhang J, Zhang JS. Renal carcinomas associated with Xp11.2 translocations: Are CT findings suggestive of the diagnosis? Clin Radiol 2014; 69(1): 45-51.
[http://dx.doi.org/10.1016/j.crad.2013.08.004] [PMID: 24156792]
[9]
Yu Z, Xin O, Wang Y, et al. Misdiagnosis of Xp 11.2 translocation / TFE E 3 gene fusion associated renal cancer with hydrothorax and literature review. Med Theory Prac 2021; 34(14): 2549-51.
[10]
Li X, Nie P, Zhang J, Hou F, Ma Q, Cui J. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: A central scar-matched retrospective study. Acta Radiol 2022; 63(2): 253-60.
[http://dx.doi.org/10.1177/0284185120988109] [PMID: 33497276]
[11]
Sudour-Bonnange H, Leroy X, Chauvet M, Classe M, Robin PM, Leblond P. Cutaneous metastases during an aggressive course of Xp11.2 translocation renal cell carcinoma in a teenager. Pediatr Blood Cancer 2014; 61(9): 1698-700.
[http://dx.doi.org/10.1002/pbc.25015] [PMID: 24585574]
[12]
Argani P, Zhong M, Reuter VE, et al. TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol 2016; 40(6): 723-37.
[http://dx.doi.org/10.1097/PAS.0000000000000631] [PMID: 26975036]
[13]
Woo S, Kim SY, Lee MS, et al. MDCT findings of renal cell carcinoma associated with Xp11.2 translocation and TFE3 gene fusion and papillary renal cell carcinoma. AJR Am J Roentgenol 2015; 204(3): 542-9.
[http://dx.doi.org/10.2214/AJR.14.12950] [PMID: 25714283]
[14]
Liu K, Xie P, Peng W, Zhou Z. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions: Findings on MRI and computed tomography imaging. J Magn Reson Imaging 2014; 40(2): 440-7.
[http://dx.doi.org/10.1002/jmri.24349] [PMID: 24136829]
[15]
Dang TT, Ziv E, Weinstein S, Meng MV, Wang Z, Coakley FV. Computed tomography and magnetic resonance imaging of adult renal cell carcinoma associated with Xp11.2 translocation. J Comput Assist Tomogr 2012; 36(6): 669-74.
[http://dx.doi.org/10.1097/RCT.0b013e3182680182] [PMID: 23192203]
[16]
Ključevšek D, Glušič M, Velikonja O. Clinical Value of Contrast-Enhanced Ultrasound in Atypical Wilms Tumor. Indian J Pediatr 2021; 88(5): 517-8.
[http://dx.doi.org/10.1007/s12098-021-03700-0] [PMID: 33651306]
[17]
Kato H, Kanematsu M, Yokoi S, et al. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: Radiological findings mimicking papillary subtype. J Magn Reson Imaging 2011; 33(1): 217-20.
[http://dx.doi.org/10.1002/jmri.22392] [PMID: 21182142]
[18]
Wilson MP, Patel D, Katlariwala P, Low G. A review of clinical and MR imaging features of renal lipid-poor angiomyolipomas. Abdom Radiol 2021; 46(5): 2072-8.
[http://dx.doi.org/10.1007/s00261-020-02835-6] [PMID: 33151360]
[19]
Wang D, Gong G, Fu Y, et al. CT imaging findings of renal epithelioid lipid-poor angiomyolipoma. Eur Radiol 2022; 32(7): 4919-30.
[http://dx.doi.org/10.1007/s00330-021-08528-y] [PMID: 35124718]
[20]
Cao H, Fang L, Chen L, et al. The value of contrast-enhanced ultrasound in diagnosing small renal cell carcinoma subtypes and angiomyolipoma. J Ultrasound Med 2022; 41(6): 1415-23.
[http://dx.doi.org/10.1002/jum.15824] [PMID: 34499770]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy